You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Conversion Disclosure
Fairmount Funds Management Llc · SEC Form 4 · Filed Jul 1, 2026
Conversion
Reported value range
Not reported
Fairmount Funds Management Llc Director / Ten Percent Owner
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jul 1, 2026
Public filing date
Jul 1, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$93.29
Jul 1, 2026
First close after public filing
$85.21
Jul 2, 2026
30-day return after filing
+13.26%
Through Jul 31, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,553,410 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001104659-26-080009
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$300.01M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA Current | Conversion | Jul 1, 2026 | Not reported |
| Oruka Therapeutics, Inc. ORKA | Sale | Jul 1, 2026 | $300.01M |
| Oruka Therapeutics, Inc. ORKA | Conversion | Jul 1, 2026 | $0 |